Metropolitan Life Insurance Company (MetLife)’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,194
| Closed | -$303K | – | 319 |
|
|
2024
Q1 | $303K | Sell |
3,194
-310
| -9% | -$26.6K | 0.01% | 582 |
|
|
2023
Q4 | $323K | Hold |
3,504
| – | – | 0.02% | 557 |
|
|
2023
Q3 | $176K | Buy |
3,504
+189
| +6% | +$10.1K | 0.01% | 740 |
|
|
2023
Q2 | $210K | Hold |
3,315
| – | – | 0.01% | 662 |
|
|
2023
Q1 | $149K | Sell |
3,315
-362
| -10% | -$16.3K | 0.01% | 789 |
|
|
2022
Q4 | $161K | Hold |
3,677
| – | – | 0.01% | 809 |
|
|
2022
Q3 | $242K | Hold |
3,677
| – | – | 0.01% | 607 |
|
|
2022
Q2 | $186K | Hold |
3,677
| – | – | 0.01% | 725 |
|
|
2022
Q1 | $235K | Sell |
3,677
-11,215
| -75% | -$805K | 0.01% | 740 |
|
|
2021
Q4 | $1.6M | Sell |
14,892
-434
| -3% | -$45.4K | 0.02% | 659 |
|
|
2021
Q3 | $1.58M | Sell |
15,326
-726
| -5% | -$67.6K | 0.02% | 642 |
|
|
2021
Q2 | $1.41M | Buy |
16,052
+1,003
| +7% | +$91.9K | 0.02% | 748 |
|
|
2021
Q1 | $1.46M | Sell |
15,049
-543
| -3% | -$54.2K | 0.02% | 710 |
|
|
2020
Q4 | $1.75M | Sell |
15,592
-136
| -0.9% | -$14.3K | 0.03% | 543 |
|
|
2020
Q3 | $1.46M | Sell |
15,728
-761
| -5% | -$58.6K | 0.02% | 548 |
|
|
2020
Q2 | $1.29M | Buy |
16,489
+236
| +1% | +$16K | 0.02% | 598 |
|
|
2020
Q1 | $950K | Buy |
16,253
+758
| +5% | +$48.8K | 0.02% | 701 |
|
|
2019
Q4 | $1.24M | Sell |
15,495
-458
| -3% | -$34.3K | 0.02% | 772 |
|
|
2019
Q3 | $1.17M | Buy |
15,953
+1,078
| +7% | +$93.2K | 0.02% | 775 |
|
|
2019
Q2 | $1.4M | Buy |
14,875
+1,578
| +12% | +$130K | 0.02% | 695 |
|
|
2019
Q1 | $1.06M | Sell |
13,297
-179
| -1% | -$13.2K | 0.02% | 845 |
|
|
2018
Q4 | $726K | Hold |
13,476
| – | – | 0.01% | 980 |
|
|
2018
Q3 | $1.05M | Hold |
13,476
| – | – | 0.02% | 904 |
|
|
2018
Q2 | $855K | Hold |
13,476
| – | – | 0.01% | 1000 |
|
|
2018
Q1 | $1.24M | Buy |
13,476
+804
| +6% | +$69.3K | 0.02% | 805 |
|
|
2017
Q4 | $956K | Sell |
12,672
-13,607
| -52% | -$957K | 0.01% | 918 |
|
|
2017
Q3 | $1.83M | Sell |
26,279
-263
| -1% | -$14.1K | 0.01% | 965 |
|
|
2017
Q2 | $1.34M | Buy |
26,542
+9,387
| +55% | +$399K | 0.01% | 1096 |
|
|
2017
Q1 | $686K | Buy |
17,155
+1,589
| +10% | +$56.9K | ﹤0.01% | 1441 |
|
|
2016
Q4 | $437K | Hold |
15,566
| – | – | ﹤0.01% | 1829 |
|
|
2016
Q3 | $462K | Hold |
15,566
| – | – | ﹤0.01% | 1757 |
|
|
2016
Q2 | $315K | Buy |
15,566
+7,281
| +88% | +$132K | ﹤0.01% | 2001 |
|
|
2016
Q1 | $150K | Sell |
8,285
-598
| -7% | -$10.4K | ﹤0.01% | 2343 |
|
|
2015
Q4 | $234K | Hold |
8,883
| – | – | ﹤0.01% | 2142 |
|
|
2015
Q3 | $190K | Sell |
8,883
-71
| -0.8% | -$1.96K | ﹤0.01% | 2315 |
|
|
2015
Q2 | $237K | Buy |
+8,954
| New | +$256K | ﹤0.01% | 2284 |
|
Other funds holding BPMC
RSCM
Metropolitan Life Insurance Company (MetLife)'s BPMC Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Blueprint Medicines (BPMC) in Q2 2024, closing a stake of 3,194 shares — an estimated $303K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BPMC in Q2 2015 and held it in 36 quarters. The position peaked at $1.83M in Q3 2017. 305 funds tracked by Wall St. Rank hold BPMC as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Blueprint Medicines position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 3,194 Blueprint Medicines shares in Q2 2024, an estimated $303K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Blueprint Medicines in Q2 2015 and held it in 36 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Blueprint Medicines position peaked at $1.83M in Q3 2017.
- 305 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.